Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice

被引:41
作者
Shiota, Atsushi [1 ]
Yamamoto, Koichi [1 ]
Ohishi, Mitsuru [1 ]
Tatara, Yuji [1 ]
Ohnishi, Miyuki [1 ]
Maekawa, Yoshihiro [1 ]
Iwamoto, Yoshihiro [1 ]
Takeda, Masao [1 ]
Rakugi, Hiromi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan
关键词
ACE2; diabetic nephropathy; renin-angiotensin system; ANGIOTENSIN-CONVERTING ENZYME-2; CONGENITAL NEPHROTIC SYNDROME; KIDNEY-DISEASE; RECEPTOR ANTAGONIST; NEPHRIN EXPRESSION; NEPHROPATHY; PROTEIN; GENE; VEGF; ALBUMINURIA;
D O I
10.1038/hr.2009.231
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
As angiotensin-converting enzyme-2 (ACE2) was identified as a negative regulator of the renin-angiotensin system, there have been many reports concerning its role in several tissues, including the kidney. However, the role of ACE2 during the development of diabetic nephropathy remains undetermined, as previous reports did not necessarily support a protective role against renal injury. Thus, we performed detailed observations of kidneys in ACE2-knockout (ACE2-KO) mice at early (4 weeks) and advanced (18 weeks) stages of diabetes. ACE2-KO and wild-type C57BL/6 mice were rendered diabetic by intraperitoneal injection of streptozotocin. Diabetic ACE2-KO mice showed earlier onset and more severe progression of albuminuria than those did wild-type mice. The elevation of serum creatinine and urea nitrogen levels at 18 weeks of diabetes was more prominent in ACE2-KO mice. Periodic acid-Schiff-stained cross-section of diabetic ACE2-KO mice showed a more severe time-dependent increase in glomerular/tubulointerstitial damage than did that of wild-type mice, confirmed by the immunostaining of alpha-smooth muscle actin, collagen IV and F4-80 antigen. Glomeruli of diabetic ACE2-KO mice showed earlier and more severe decrease in the expression of nephrin, whose degradation is involved in the onset of albuminuria, and more potent increase of vascular endothelial growth factor expression. In addition, treatment with AT1 receptor blocker olmesartan significantly, but not totally, ameliorated the functional and morphological deterioration of diabetic nephropathy in ACE2-KO mice. These results suggest that ACE2 might continuously protect from both glomerular and tubulointerstitial injury during the development of diabetic nephropathy. The renal-protective effect of ACE2 might involve more than just suppressing angiotensin II-mediated AT1 receptor signaling. Hypertension Research (2010) 33, 298-307; doi:10.1038/hr.2009.231; published online 26 February 2010
引用
收藏
页码:298 / 307
页数:10
相关论文
共 42 条
[11]   Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy [J].
de Haan, JB ;
Stefanovic, N ;
Nikolic-Paterson, D ;
Scurr, LL ;
Croft, KD ;
Mori, TA ;
Hertzog, P ;
Kola, I ;
Atkins, RC ;
Tesch, GH .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (03) :F544-F551
[12]   A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 [J].
Donoghue, M ;
Hsieh, F ;
Baronas, E ;
Godbout, K ;
Gosselin, M ;
Stagliano, N ;
Donovan, M ;
Woolf, B ;
Robison, K ;
Jeyaseelan, R ;
Breitbart, RE ;
Acton, S .
CIRCULATION RESEARCH, 2000, 87 (05) :E1-E9
[13]   Nephrin expression is reduced in human diabetic nephropathy - Evidence for a distinct role for glycated albumin and angiotensin II [J].
Doublier, S ;
Salvidio, G ;
Lupia, E ;
Ruotsalainen, V ;
Verzola, D ;
Deferrari, G ;
Camussi, G .
DIABETES, 2003, 52 (04) :1023-1030
[14]   Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages [J].
Gurley, Susan B. ;
Coffman, Thomas M. .
EXPERIMENTAL PHYSIOLOGY, 2008, 93 (05) :538-542
[15]   Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis [J].
Hamming, I ;
Timens, W ;
Bulthuis, MLC ;
Lely, AT ;
Navis, GJ ;
van Goor, H .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :631-637
[16]   Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man [J].
Hohenstein, B ;
Hausknecht, B ;
Boehmer, K ;
Riess, R ;
Brekken, RA ;
Hugo, CPM .
KIDNEY INTERNATIONAL, 2006, 69 (09) :1654-1661
[17]   Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy [J].
Hovind, P ;
Tarnow, L ;
Oestergaard, PB ;
Parving, HH .
KIDNEY INTERNATIONAL, 2000, 57 :S56-S61
[18]   Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: Effects of an ACE inhibitor and an angiotensin II receptor antagonist [J].
Kakizawa, H ;
Itoh, Y ;
Imamura, S ;
Matsumoto, T ;
Ishiwata, Y ;
Ono, Y ;
Yamamoto, K ;
Kato, T ;
Hayakawa, N ;
Oda, N ;
Goto, Y ;
Nagasaka, A ;
Senda, T ;
Itoh, M .
HORMONE AND METABOLIC RESEARCH, 2004, 36 (07) :458-464
[19]   Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome [J].
Kestila, M ;
Lenkkeri, U ;
Mannikko, M ;
Lamerdin, J ;
McCready, P ;
Putaala, H ;
Ruotsalainen, V ;
Morita, T ;
Nissinen, M ;
Herva, R ;
Kashtan, CE ;
Peltonen, L ;
Holmberg, C ;
Olsen, A ;
Tryggvason, K .
MOLECULAR CELL, 1998, 1 (04) :575-582
[20]   Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy [J].
Kim, NH ;
Oh, JH ;
Seo, JA ;
Lee, KW ;
Kim, SG ;
Choi, KM ;
Baik, SH ;
Choi, DS ;
Kang, YS ;
Han, SY ;
Han, KH ;
Ji, YH ;
Cha, DR .
KIDNEY INTERNATIONAL, 2005, 67 (01) :167-177